International Journal of Chronic Diseases / 2017 / Article / Tab 4

Research Article

Lipid Profile in Tuberculosis Patients with and without Human Immunodeficiency Virus Infection

Table 4

ATT response on lipid profile concentration in HIV−TB+ patients after treatment.

Lipid profile nameHIV−TB+
at M0
at M6
HIV−TST+HIV−TST− HIV−TB+ (M6) versus
HIV−TB+ (M0)
HIV−TB+ (M6) versus
HIV+TB+ (M6) versus

TC108 ( 87–130)137 (122–166)149 (140.5–162)158 (150–192)
TG75 (66–84)76 (65–87)83.5 (73–110.5)119 (82–119)
LDL-C59.3 (46.9–73.2)71.2 (56.8–92.4)73.35 (63.8–87.2)80.4 (73.5–105.1)
HDL-C26.5 (21.1–31.8)35.9 (32.4–45.1)42.4 (37.05– 49.3)44.7 (37.4–54.6)
CD4+234 (146–345)345 (234–566)333 (234–478)345 (234–401)

Median (interquartile range) of lipid profile concentration and CD4+ T-cell count values are shown. Significant differences between HIV−TB+ patients at M0 and M6 were determined using Wilcoxon signed-rank test. Significant differences between HIV−TB+ patients at M6 and HIV−TST+ or HIV−TST− at M0 were determined using Wilcoxon Mann–Whitney test.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.